In the fall of 2024, Louisiana implemented the nation’s first-ever law designating mifepristone and misoprostol as controlled substances. That put the pills in the same category as opioids and anxiety medications that have a high risk of dependency and abuse, even though mifepristone and misoprostol have no recreational use, aren’t stimulants or sedatives, and are not addictive.
“They do not meet the definition or intent of what a controlled …